To define the molecular mechanisms involved in paclitaxel induction of proapoptotic paracrine effects, we evaluated BCL-2 family member expression changes in breast cancer cell lines exposed to CM from paclitaxel-treated donors. The gene discussed is BCL2; the disease is breast carcinoma.